Anti-transferrin receptor monoclonal antibody: A novel immunosuppressant

Transplantation

Volumn 65, Issue 1, 1998, Pages 6-9

  Woodward, Jennifer E ^a   Bayer, Allison L ^a   Chavin, Kenneth D ^c   Boleza, Kimberly A ^b   Baliga, Prabhakar ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNITY, CELLULAR; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; RECEPTORS, TRANSFERRIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031936264     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801150-00003     Document Type: Article

References (20)

1. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev 1987; 67: 520.
2. May WS Jr, Cuatrecasas P. Transferrin receptor: its biological significance. J Membr Biol 1985; 88: 205.
3. Pattanapanyasat K, Hoy TG. Expression of cell surface transferrin receptor and intracellular ferritin after in vitro stimulation of peripheral blood T lymphocytes. Eur J Haematol 1991; 47: 140.
4. Weiss A. Structure and function of the T cell antigen receptor. J Clin Invest 1990; 86: 1015.
5. Marrack P, Kappler J. The T cell receptor. Science 1987; 238: 1073.
6. Salmeron A, Borroto A, Fresno M, Crumpton MJ, Ley SC, Alarcon B. Transferrin receptor induces tyrosine phosphorylation in T cells and is physically associated with the TCR zeta-chain. J Immunol 1995; 154: 1675.
7. Lesley J, Schulte R, Woods J. Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments. Exp Cell Res 1989; 182: 215.
8. Kudoh S, Stanley J, Edinger MG, et al. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer 1994; 58: 369.
9. Sauvage CA, Mendelsohn JC, Lesley JF, Trowbridge IS. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia. Cancer Res 1987; 47: 747.
10. Trowbridge IS. Transferrin receptor as a potential therapeutic target. Prog Allergy 1988; 45: 121.
11. Lesley JF, Schulte RJ. Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies. Mol Cell Biol 1985; 5: 1814.
12. Aihara Y, Buhring HJ, Aihara M, Klein J. An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol 1986; 16: 1391.
13. Woodward JE, Qin L, Chavin KD, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation 1996; 62: 1011.
14. Baliga P, Chavin KD, Qin L, et al. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 1994; 58: 1082.
15. Chavin KD, Qin L, Lin J, Woodward JE, Baliga P, Bromberg JS. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. Ann Surg 1993; 218: 492.
16. Judd KP, Trentin JJ. Cardiac transplantation in mice. I. Factors influencing the take and survival of heterotopic grafts. Transplantation 1971; 11: 298.
17. Finberg R, Burakoff SJ, Benacerraf B, Greene MI. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells. J Immunol 1979; 123: 1210.
18. Golding S, Young SP. Iron requirements of human lymphocytes: relative contributions of intra- and extra-cellular iron. Scand J Immunol 1995; 41: 229.
19. Or R, Kovar J, Domenico J, Gelfand EW. Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells. Clin Immunol Immunopathol 1992; 62: 314.
20. Nakamura A, Sone S, Nabioullin R, et al. Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cells. Clin Exp Immunol 1993; 92: 174.